126 related articles for article (PubMed ID: 8557001)
21. Molar potency is not predictive of the speed of onset of atracurium.
Kopman AF; Klewicka MM; Neuman GG
Anesth Analg; 1999 Oct; 89(4):1046-9. PubMed ID: 10512288
[TBL] [Abstract][Full Text] [Related]
22. The pharmacology of rocuronium bromide (ORG 9426).
Wicks TC
AANA J; 1994 Feb; 62(1):33-8. PubMed ID: 8122487
[TBL] [Abstract][Full Text] [Related]
23. Muscle relaxants: a clinical update.
Buzello W; Diefenbach C; Nigrovic V
Acta Anaesthesiol Scand Suppl; 1996; 109():165-7. PubMed ID: 8901994
[TBL] [Abstract][Full Text] [Related]
24. Meta-analysis of the differences in the time to onset of action between rocuronium and vecuronium.
Nava-Ocampo AA; Velázquez-Armenta Y; Moyao-García D; Salmerón J
Clin Exp Pharmacol Physiol; 2006; 33(1-2):125-30. PubMed ID: 16445711
[TBL] [Abstract][Full Text] [Related]
25. Priming studies with rocuronium and vecuronium.
Redai I; Feldman SA
Eur J Anaesthesiol Suppl; 1995 Sep; 11():11-3. PubMed ID: 8556997
[TBL] [Abstract][Full Text] [Related]
26. Use of intermediate acting muscle relaxants by infusion: the future.
Mirakhur RK; McCourt KC; Kumar N
Acta Anaesthesiol Belg; 1997; 48(1):29-34. PubMed ID: 9099306
[TBL] [Abstract][Full Text] [Related]
27. Rocuronium bromide in dental day case anaesthesia--a comparison with atracurium and vecuronium.
Chetty MS; Pollard BL; Wilson A; Healy TE
Anaesth Intensive Care; 1996 Feb; 24(1):37-41. PubMed ID: 8669652
[TBL] [Abstract][Full Text] [Related]
28. Choice of the muscle relaxant for rapid-sequence induction.
Sparr HJ
Eur J Anaesthesiol Suppl; 2001; 23():71-6. PubMed ID: 11766251
[TBL] [Abstract][Full Text] [Related]
29. Skin reactions to intradermal neuromuscular blocking agent injections: a randomized multicenter trial in healthy volunteers.
Mertes PM; Moneret-Vautrin DA; Leynadier F; Laxenaire MC
Anesthesiology; 2007 Aug; 107(2):245-52. PubMed ID: 17667568
[TBL] [Abstract][Full Text] [Related]
30. Economic aspects of different muscle relaxant regimens.
Suttner S; Boldt J; Piper SN; Schmidt C; Kumle B
Anasthesiol Intensivmed Notfallmed Schmerzther; 2000 May; 35(5):300-5. PubMed ID: 10858839
[TBL] [Abstract][Full Text] [Related]
31. Performance assessment of an adaptive model-based feedback controller: comparison between atracurium, mivacurium, rocuronium and vecuronium.
Kansanaho M; Olkkola KT
Int J Clin Monit Comput; 1996 Nov; 13(4):217-24. PubMed ID: 9080242
[TBL] [Abstract][Full Text] [Related]
32. Recovery of neuromuscular function after a combination of mivacurium and rocuronium.
Stout RG; Shine TS; Silverman DG; Brull SJ
Yale J Biol Med; 2004 Sep; 77(5-6):149-54. PubMed ID: 15989744
[TBL] [Abstract][Full Text] [Related]
33. Rocuronium onset of action: a comparison with atracurium and vecuronium.
Bartkowski RR; Witkowski TA; Azad S; Lessin J; Marr A
Anesth Analg; 1993 Sep; 77(3):574-8. PubMed ID: 8103649
[TBL] [Abstract][Full Text] [Related]
34. Atracurium, cisatracurium, vecuronium and rocuronium in patients with renal failure.
Della Rocca G; Pompei L; Coccia C; Costa MG; Cecchini V; Vilardi V; Pietropaoli P
Minerva Anestesiol; 2003; 69(7-8):605-11, 612, 5. PubMed ID: 14564242
[TBL] [Abstract][Full Text] [Related]
35. Dose-response, time-course of action and recovery of rocuronium bromide in children during halothane anaesthesia.
Motsch J; Leuwer M; Böttiger BW; Bach A; Schönstedt R; Martin E
Eur J Anaesthesiol Suppl; 1995 Sep; 11():73-8. PubMed ID: 8557011
[TBL] [Abstract][Full Text] [Related]
36. The effect of priming with vecuronium and rocuronium on young and elderly patients.
Aziz L; Jahangir SM; Choudhury SN; Rahman K; Ohta Y; Hirakawa M
Anesth Analg; 1997 Sep; 85(3):663-6. PubMed ID: 9296427
[TBL] [Abstract][Full Text] [Related]
37. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study.
de Boer HD; Driessen JJ; Marcus MA; Kerkkamp H; Heeringa M; Klimek M
Anesthesiology; 2007 Aug; 107(2):239-44. PubMed ID: 17667567
[TBL] [Abstract][Full Text] [Related]
38. Molar potency is predictive of the speed of onset of neuromuscular block for agents of intermediate, short, and ultrashort duration.
Kopman AF; Klewicka MM; Kopman DJ; Neuman GG
Anesthesiology; 1999 Feb; 90(2):425-31. PubMed ID: 9952148
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics and pharmacokinetic/dynamic relationship of rocuronium bromide in humans.
Wierda JM; Proost JH; Schiere S; Hommes FD
Eur J Anaesthesiol Suppl; 1994; 9():66-74. PubMed ID: 7925212
[TBL] [Abstract][Full Text] [Related]
40. [New muscle relaxants].
Diefenbach C; Buzello W
Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Feb; 31(1):2-8. PubMed ID: 8868525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
